Politico August 8, 2024
WASHINGTON WATCH
The FDA is expected to decide this week whether to approve an MDMA, or psychedelic, therapy for post-traumatic stress disorder, which affects about 7 percent of veterans.
Rep. Jack Bergman (R-Mich.) supports the therapeutic use of psychedelic drugs — and thinks the FDA should get on board. He says he’s been interested in veteran mental health since 2003, when as a retired Marine Corps general, he decided to look into how members of the Individual Ready Reserve were doing in their off-duty lives.
“These fine young marines had served their time and left active duty, and they were kind of out there in the darkness,” he said. “That’s when I started to really take a look at what...
Today's Sponsors
Today's Sponsor